MUSTANG BIO, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
MUSTANG BIO, INC. (MBIO) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $0.00.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $0.00.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $7.00K, a 95.39% decline from fiscal 2024.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $152.00K, a 58.36% decline from fiscal 2023.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $365.00K, a 18.51% increase from fiscal 2022.
- MUSTANG BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $308.00K, a 121.58% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $7.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $7.00K 10-Q · filed 2025-11-07 | $31.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.00K 10-Q · filed 2026-08-05 | $31.00K derived: sum of 3 quarters · filed 2026-08-05 | $31.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-05 | $31.00K derived: sum of 2 quarters · filed 2026-05-05 | $31.00K derived: sum of 3 quarters · filed 2026-05-05 | -$252.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $24.00K derived: sum of 2 quarters · filed 2026-03-19 | -$259.00K derived: sum of 3 quarters · filed 2026-03-19 | $152.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$283.00K derived: sum of 2 quarters · filed 2025-11-07 | $128.00K 10-Q · filed 2025-11-07 | $207.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $128.00K 10-Q · filed 2025-08-08 | $207.00K derived: sum of 3 quarters · filed 2025-08-08 | $289.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $411.00K 10-Q · filed 2025-05-14 | $490.00K derived: sum of 2 quarters · filed 2025-05-14 | $572.00K derived: sum of 3 quarters · filed 2025-05-14 | $670.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $161.00K derived: sum of 2 quarters · filed 2025-03-28 | $259.00K derived: sum of 3 quarters · filed 2025-03-28 | $365.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $180.00K derived: sum of 2 quarters · filed 2024-11-08 | $286.00K 10-Q · filed 2024-11-08 | $392.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $204.00K 10-Q · filed 2024-08-13 | $310.00K derived: sum of 3 quarters · filed 2024-08-13 | $432.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $106.00K 10-Q · filed 2024-05-15 | $212.00K derived: sum of 2 quarters · filed 2024-05-15 | $334.00K derived: sum of 3 quarters · filed 2024-05-15 | $375.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $228.00K derived: sum of 2 quarters · filed 2024-03-11 | $269.00K derived: sum of 3 quarters · filed 2024-03-11 | $308.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $163.00K derived: sum of 2 quarters · filed 2023-11-14 | $202.00K 10-Q · filed 2023-11-14 | $239.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $80.00K 10-Q · filed 2023-08-14 | $117.00K derived: sum of 3 quarters · filed 2023-08-14 | $151.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $39.00K 10-Q · filed 2023-05-12 | $76.00K derived: sum of 2 quarters · filed 2023-05-12 | $110.00K derived: sum of 3 quarters · filed 2023-05-12 | $150.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $71.00K derived: sum of 2 quarters · filed 2023-03-30 | $111.00K derived: sum of 3 quarters · filed 2023-03-30 | $139.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $74.00K derived: sum of 2 quarters · filed 2022-11-14 | $102.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $68.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $28.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $108.00K 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |